Drug Type Synthetic peptide |
Synonyms- |
Target |
Action antagonists, inhibitors |
Mechanism GPX4 antagonists(glutathione peroxidase 4 antagonists), TrxR1 inhibitors(thioredoxin reductase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Preclinical | India | 12 Dec 2024 |






